Showing results (11-20 of 87) with videos related to
Sort By:
Pageof 9
Blood|October 26, 2000
Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow culturesK Brasel, T De Smedt, J L Smith, et al.International Reviews of Immunology|May 9, 2001
Derivation of dendritic cells from myeloid and lymphoid precursorsL Wu, S Vandenabeele, K GeorgopoulosJournal of Immunology (Baltimore, Md. : 1950)|September 1, 1985
Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23C R Maliszewski, E D Ball, R F Graziano, et al.The Journal of Experimental Medicine|January 1, 1994
Cytokine-mediated regulation of chronic intestinal helminth infectionK J Else, F D Finkelman, C R Maliszewski, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1996
Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible miceA Keane-Myers, C R Maliszewski, F D Finkelman, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1994
CD40-activated surface IgD-positive lymphocytes constitute the long term IL-4-dependent proliferating B cell poolL Galibert, I Durand, J Banchereau, et al.The Journal of Experimental Medicine|December 1, 1990
Expression cloning of a human Fc receptor for IgAC R Maliszewski, C J March, M A Schoenborn, et al.Molecular Immunology|January 1, 1987
Monoclonal antibodies that bind to the My23 human myeloid cell surface molecule: epitope analysis and antigen modulation studiesC R Maliszewski, J Currier, J Fisher, et al.The Journal of Experimental Medicine|December 8, 1998
Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvantB Pulendran, J L Smith, M Jenkins, et al.Revue Neurologique|March 1, 1997
[Nicotine and worsening myasthenia]T Moreau, S Vukusic, S Vandenabeele, et al.Pageof 9